Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Yan-Jie ChenShu-Neng LuoLing DongTao-Tao LiuXi-Zhong ShenNing-Ping ZhangLi LiangPublished in: Journal of translational medicine (2021)
On account of differential expression, IRF family members can help to predict both response to immunotherapy and clinical prognosis of patients with CRC. Our bioinformatic investigation not only gives a preliminary picture of the genetic features as well as tumor microenvironment, but it may provide a clue for further experimental exploration and verification on IRF family members in CRC.